The Retina Center at Pali Momi Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2007
NCT00424710
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

ranibizumab (lucentis) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Vascular Diseases (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1